Merrimack Pharmaceuticals, Inc. NASDAQ:MACK

Founder-led company
Financial Health
0
1
2
3
4
5
6
7
8
9

Merrimack Pharmaceuticals stock price monthly change

+2.92%
month

Merrimack Pharmaceuticals stock price quarterly change

+8.15%
quarter

Merrimack Pharmaceuticals stock price yearly change

+18.02%
year

Merrimack Pharmaceuticals key metrics

Market Cap
223.97M
Enterprise value
N/A
P/E
-8.91
EV/Sales
N/A
EV/EBITDA
4.51
Price/Sales
N/A
Price/Book
0.98
PEG ratio
0.27
EPS
-1.70
Revenue
N/A
EBITDA
-2.25M
Income
-24.54M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Merrimack Pharmaceuticals stock price history

Merrimack Pharmaceuticals stock forecast

Merrimack Pharmaceuticals financial statements

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Profit margin
Jun 2023 0 -391K
Sep 2023 0 -279K
Dec 2023 0 -240K
Mar 2024 0 -23.63M
199.40%
Yield TTM
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Payout ratio
Payout ratio 0%
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Dividend Yield
2019 63.48%
2020
2021
2022
2023
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Debt to assets
Jun 2023 19448000 411K 2.11%
Sep 2023 19299000 493K 2.55%
Dec 2023 19188000 441K 2.3%
Mar 2024 244322000 22.67M 9.28%
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Cash Flow
Jun 2023 -668K -8.81M 209K
Sep 2023 -203K -3.84M 0
Dec 2023 -295K 68K 133K
Mar 2024 -1.31M 228M 1.48M

Merrimack Pharmaceuticals other data

16.56% -39.77%
of MACK is owned by hedge funds
2.24M -5.31M
shares is hold by hedge funds

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK): Insider trades (number of shares)
Period Buy Sel
Jan 2023 189353 0
Mar 2023 160590 0
Aug 2023 225550 0
Nov 2023 74268 0
Dec 2023 150600 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ANDERSEN ERIC director Common Stock 857 $13.35 $11,441
Purchase
ANDERSEN ERIC director Common Stock 48,693 $13.15 $640,313
Purchase
ANDERSEN ERIC director Common Stock 76,384 $12.85 $981,534
Purchase
ANDERSEN ERIC director Common Stock 24,666 $12.85 $316,958
Purchase
ANDERSEN ERIC director Common Stock 235 $12.5 $2,938
Purchase
ANDERSEN ERIC director Common Stock 65 $12.5 $813
Purchase
ANDERSEN ERIC director Common Stock 39,283 $12.5 $491,038
Purchase
ANDERSEN ERIC director Common Stock 10,887 $12.5 $136,088
Purchase
ANDERSEN ERIC director Common Stock 7,810 $12.19 $95,220
Purchase
ANDERSEN ERIC director Common Stock 2,165 $12.19 $26,396
Patent
Application
Filling date: 28 Feb 2020 Issue date: 8 Sep 2022
Application
Filling date: 18 Sep 2019 Issue date: 2 Dec 2021
Application
Filling date: 16 Mar 2017 Issue date: 3 Oct 2019
Application
Filling date: 5 Nov 2018 Issue date: 26 Sep 2019
Insider Compensation
Dr. Ulrik B. Nielsen (1972) Co-Founder & Independent Director $76,880
Mr. Gary L. Crocker M.B.A., MBA (1952) Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, Chief Executive Officer & Chairman
$74,500
  • When is Merrimack Pharmaceuticals's next earnings date?

    Unfortunately, Merrimack Pharmaceuticals's (MACK) next earnings date is currently unknown.

  • Does Merrimack Pharmaceuticals pay dividends?

    Yes, Merrimack Pharmaceuticals pays dividends and its trailing 12-month yield is 199.41% with 0% payout ratio. The last Merrimack Pharmaceuticals stock dividend of $0.5 was paid on 23 Dec 2019.

  • How much money does Merrimack Pharmaceuticals make?

    Merrimack Pharmaceuticals has a market capitalization of 223.97M.

  • What is Merrimack Pharmaceuticals's stock symbol?

    Merrimack Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "MACK".

  • What is Merrimack Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Merrimack Pharmaceuticals?

    Shares of Merrimack Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Merrimack Pharmaceuticals's key executives?

    Merrimack Pharmaceuticals's management team includes the following people:

    • Dr. Ulrik B. Nielsen Co-Founder & Independent Director(age: 53, pay: $76,880)
    • Mr. Gary L. Crocker M.B.A., MBA Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, Chief Executive Officer & Chairman(age: 73, pay: $74,500)
  • Is Merrimack Pharmaceuticals founder-led company?

    Yes, Merrimack Pharmaceuticals is a company led by its founder Dr. Ulrik B. Nielsen.

  • When Merrimack Pharmaceuticals went public?

    Merrimack Pharmaceuticals, Inc. is publicly traded company for more then 13 years since IPO on 29 Mar 2012.

  • What is Merrimack Pharmaceuticals's official website?

    The official website for Merrimack Pharmaceuticals is merrimack.com.

  • Where are Merrimack Pharmaceuticals's headquarters?

    Merrimack Pharmaceuticals is headquartered at One Broadway, Cambridge, MA.

  • How can i contact Merrimack Pharmaceuticals?

    Merrimack Pharmaceuticals's mailing address is One Broadway, Cambridge, MA and company can be reached via phone at +61 77208606.

Merrimack Pharmaceuticals company profile:

Merrimack Pharmaceuticals, Inc.

merrimack.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

One Broadway
Cambridge, MA 02142

CIK: 0001274792
ISIN: US5903282094
CUSIP: 590328209